SEC Form 4 · accession 0000911916-16-000581
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stuart G. Kleopfer
Officer — President, Americas
Period of report
Jun 9, 2016
Accepted (ET)
Jun 10, 2016 · 2:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 9, 2016 | S | 9,788 | $119.3861 | D | 7,609 | D | |
| Common StockF2 | Jun 9, 2016 | S | 1,212 | $119.9703 | D | 6,397 | D | |
| Common Stock | holding | — | — | — | 533 | I | By 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the sale of 9,788 shares in multiple transactions, ranging in price from $118.92 to $119.87 per share, resulting in a weighted average sale price of $119.3861. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F2Represents the sale of 1,212 shares in multiple transactions, ranging in price from $119.92 to $120.05 per share, resulting in a weighted average sale price of $119.9703. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.